Sutro Biopharma, Inc. (STRO)
8.93
-0.20
(-2.19%)
USD |
NASDAQ |
Dec 18, 16:00
8.76
-0.17
(-1.90%)
After-Hours: 20:00
Sutro Biopharma EPS Diluted (Quarterly): -6.699 for Sept. 30, 2025
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Daré Bioscience, Inc. | -0.2793 |
| Syndax Pharmaceuticals, Inc. | -0.7009 |
| NovaBay Pharmaceuticals, Inc. | -0.22 |
| Palatin Technologies, Inc. | 4.258 |
| Theriva Biologics, Inc. | -0.4507 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | -56.86M |
| Revenue (Quarterly) | 9.693M |
| Total Expenses (Quarterly) | 66.55M |
| Enterprise Value | 136.02M |
| Gross Profit Margin (Quarterly) | 80.40% |
| Profit Margin (Quarterly) | -586.6% |
| Earnings Yield | -198.8% |
| Normalized Earnings Yield | -170.90 |